T he notion that the clinical manifestations of cardiovascular disease do not occur randomly throughout the course of the day has been accepted for Ͼ4 decades. Cohort studies documenting the time of chest pain onset demonstrated a morning predilection for the presentation of myocardial infarction. 1 At the time, however, it was difficult to discern a morning rise in the incidence of myocardial infarction from the simple realization of longstanding nocturnal symptoms on awakening. With the advent of studies to limit myocardial infarct size, it became possible to accurately identify the myocardial infarction onset by the timedependent increase in circulating creatine kinase levels, and these data confirmed a distribution roughly peaking in the hours between 6 AM and noon. 2 It soon became clear that other manifestations of cardiovascular disease, such as sudden cardiac death, stroke, and myocardial ischemia all exhibited similar time-of-day dependence, as reviewed by Muller. 3 If one corrects for individual variations in the time of sleep cessation, the preponderance of events occur within the first 3 hours after awakening. 4
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The clustering of cardiovascular events to a specific time of day prompted considerable investigation into potential causes, with particular attention to phenomena that exhibit a preference for the morning hours. Arterial pressure was noted to have a rhythmic pattern characterized by a nadir at 3 AM followed by a rise to peak pressures before noon. Because heart rate exhibits a similar pattern, one could suppose increased adrenergic tone might contribute to the morning clustering of cardiovascular disease events. Indeed, platelets are more susceptible to stimulation soon after awakening when circulating catecholamine levels are greatest. 5 Several circulating factors such as cortisol and tissue-type plasminogen activator 6 exhibit rhythmic variation that could, in principle, contribute to the onset of cardiovascular disease.
In fact, most aspects of physiology vary on a rhythmic basis. Even though these rhythms could be generated as simple passive responses to an environment that changes over the day, many rhythms persist with a cycle length near 24 hours, even in constant environmental conditions. These endogenous rhythms are termed circadian rhythms, whereas rhythms observed in the presence of a rhythmic environment are termed daily or diurnal rhythms. In mammals, the most important environmental cue for synchronizing circadian rhythms to the 24-hour solar day is the daily light-dark cycle. 7, 8 When placed in constant darkness, rhythms of activity, sleeping and waking, body temperature, food intake, blood pressure, heart rate, and myriad other end points persist. 7, 8 A central pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus orchestrates this rhythmicity, maintaining internal temporal order so that, for example, intestinal glucose transporters are expressed even before the animal eats, 9 thus improving efficiency by predicting recurring events rather than merely reacting to them. The SCN receive light input via the retina and communicate timing information to other tissues by multiple redundant mechanisms (Figure, A) . 8 These output pathways include hormonal rhythms (eg, cortisol and melatonin), autonomic activity, and regulation of the timing of feeding and activity, which in turn impose additional cues on peripheral tissues. 10 Individual neurons within the SCN contain the biochemical machinery necessary to measure out 24 hours, and the population of Ϸ10 000 SCN neurons communicate and dictate "SCN central time." Remarkably, the capacity for rhythmicity is not restricted to the SCN, and most organs and cell types express rhythms in gene expression that persist when isolated in vitro. 10 Thus, the SCN serve as a master pacemaker, a population of neuronal oscillators that coordinate a body full of oscillators. The light-dark cycle sets the timing of the SCN neuronal oscillations and also reinforces and amplifies many physiological and behavioral rhythms. When an animal (or human) is placed in constant darkness, rhythms persist, and they do so with the appropriate temporal order but without coordination to the solar day. In the absence of a functional circadian-clock, rhythmicity is artificially imposed by the lighting cycle. Only when a circadian clock is studied in constant conditions can its true impact be seen.
The mechanisms by which individual mammalian cells can measure time in Ϸ24-hour increments have been revealed over the last 12 years (Figure, B ). The core of the circadianclock mechanism is a molecular feedback loop that produces and destroys key proteins in an oscillating manner with a cycle length of 24 hours. At the heart of this mechanism are 3 basic helix-loop-helix transcription factors, CLOCK, BMAL1, and NPAS2. 8, 11 These proteins pair up to form heterodimers (CLOCK:BMAL1 or NPAS2:BMAL1), which are transcriptional activators. Among the targets of these activator complexes are the Period (Per) and Cryptochrome (Cry) genes. The protein products of these genes (specifically The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
From the Departments of Medicine (J.F.K.) and Neurobiology PER1, PER2, CRY1 and CRY2), form complexes that inhibit the transcriptional activity of the activator complex, thus closing the negative feedback loop (Figure, B ). Posttranslational modification and degradation of the negative regulators prevent the feedback loop from closing too soon, resulting in a molecular feedback loop oscillating with a period of 24 hours. It is important to keep in mind that in parallel to this rhythmicity of the so-called "clock genes" (gene families necessary for the core molecular loop), other genes are being rhythmically activated and inhibited. These genes include clock-controlled genes, which respond directly to the waxing and waning of the activator and repressor complexes, as well as other transcription factors. These transcription factors (both activators and inhibitors) generate second-order rhythms of expression in other genes and can also modify the time of expression of genes affected by the activator complex. The overall impact of this molecular oscillation is stunning: Microarray studies estimate that as much as 5% to 10% of the genome is rhythmically expressed, as reviewed by Duffield. 12 However, the specific 5% to 10% of genes rhythmically expressed actually varies by tissue.
Studies with knockout mice show that disruption of genes within the core clock mechanism leads to loss of circadian rhythmicity. 8 The only single gene that leads to loss of behavioral and cellular rhythmicity when disrupted is Bmal1. 13 Other genes within the circadian clockwork have at least partial redundancy with other members of their gene family, such that disruption of Ͼ1 gene is necessary to produce an arrhythmic phenotype. This functional redundancy is the case for the Per genes (Per1 and Per2), Cry genes (Cry1 and Cry2), and also for Clock and the closely related gene Npas2. 11 However, a mutation of the Clock gene has been identified that leads to production of a mutant protein lacking the residues encoded by exon 19. 14 The CLOCK protein lacking exon 19 is devoid of transcriptional activity and apparently disrupts rhythms by sequestering BMAL1 in nonproductive complexes. Mice homozygous for this mutant allele of Clock actually have a more severe phenotype than Clock knockout mice, losing rhythmicity within several cycles in constant darkness. 11, 14 In this issue of Circulation, Anea and colleagues investigate chronic vascular adaptation as a function of the molecular components of the circadian clock. 15 Normally, chronic reductions in flow are associated with intimal thickening and inward remodeling of the lumen to reflect the lower flow demands. 16 However, in mice with disrupted circadian rhythmicity due to deletion of the essential clock gene Bmal1, 13 intimal thickening is accentuated and no inward remodeling has occurred, indicating a failure to adapt to changing flow. 15 In older mice, this defect was accentuated and associated with a predisposition to thrombus formation in the ligated artery. These pathological arterial responses were unequivocally reproduced in another animal model, Clock mutant mice under arrhythmic conditions, clearly establishing that circa- dian rhythms at the molecular level have important implications for vascular homeostasis.
The approach by Anea and coworkers involved studying mice with alterations in 2 important components of the molecular circadian mechanism, CLOCK and BMAL1. 15 As noted above, these genes encode transcription factors, so 1 interpretation of their study is that these mutants have a vascular phenotype due to loss of the transcription factors and the resultant alterations in gene expression, but not necessarily due to a loss of rhythmic gene expression. The authors use a clever approach to address this issue. The circadian defect in Clock mutant mice is manifest under constant (dark) conditions but can be "rescued" via housing under normal light-dark cycles. Because the remodeling defect in Clock mutant mice was not evident with light-dark cycling, it is clear that rhythmic gene expression is a key element of normal vascular adaptation. This latter point has important implications in that inherent circadian defects may be prevented from producing pathology if one maintains a rhythmic environment.
The 2 pathological responses observed by Anea and colleagues with circadian disruption, loss of vascular adaptation and predisposition to thrombus, 15 are reminiscent of the defects seen in patients with vascular disease that exhibits endothelial dysfunction. 17 Indeed, animals with dysfunctional circadian rhythms exhibited severe defects in endotheliumdependent arterial relaxation that were normalized by the restoration of rhythmicity with normal light-dark cycles. The molecular mechanism responsible for abnormal endothelial function appeared due to an inability to normally phosphorylate and activate endothelial nitric oxide synthase (eNOS), the enzyme responsible for endothelium-dependent nitric oxide (NO) production and, in large part, vascular homeostasis. 18 The findings of Anea and colleagues clearly indicate that rhythmic gene expression, via the circadian clock, has important implications for cardiovascular signaling. Their findings that phosphoinositide-dependent kinase 1 expression was impaired, leading to defective phosphorylation of the serine/ threonine kinase Akt, have broad implications in the vascular wall and beyond. Previous studies have demonstrated that Akt is needed for a host of vascular responses including NO bioactivity, endothelial migration, vascular remodeling, and the regulation of inflammation, as reviewed in Shiojima and Walsh. 19 Experimental animals with defective Akt signaling also exhibit a profound predilection to atherosclerosis and coronary thrombosis. 20 Beyond the vasculature, Akt is known to be important for cardiac protection in the face of ischemic injury 21 and for the regulation of both left ventricular hypertrophy and the progression to heart failure. 22 Thus, disruption of circadian rhythms has the potential to causally impair a number of homeostatic responses in both the vasculature and the heart.
Reason also exists to believe that impaired rhythmic gene expression, and the resultant defects in eNOS action will have implications beyond the vasculature. Mice lacking eNOS exhibit features of the metabolic syndrome including hypertension, hyperlipidemia, and insulin resistance. 23 It would follow, therefore, that the defective eNOS signaling observed by Anea and colleagues 15 could explain the obesity and insulin resistance seen in some models of impaired circadian rhythmicity. 24 However, it is likely that the relationship between the circadian clock and metabolism is more complex. For example, Clock mutant mice develop obesity and insulin resistance under normal light-dark cycling, 24 conditions not associated with abnormal eNOS signaling in the present study. The Bmal1 null mouse actually shows increased insulin sensitivity and hypotension, clearly opposite to the predicted consequences of impaired eNOS activation. No doubt, more information is needed to understand the complete relationship between the circadian-clock components and metabolism.
So how might disruption of circadian rhythms alter the expression of cardiovascular disease? One hint comes from work in golden hamsters heterozygous for the mutation tau, which causes a shift to a 22-hour circadian period and results in fragmentation of diurnal activity in 24-hour light-dark cycles. The fragmented activity results in premature death characterized by dilated cardiomyopathy, interstitial cardiac fibrosis, and progressive renal impairment. 25 If the animals were kept in a 22-hour light-dark cycle (concordant with their genotype), no fragmentation of activity and no evidence of cardiomyopathy or renal disease were evident. These data are consistent with observations in aged mice that phase advancing (shifting) the light cycle (as in jet lag) increases mortality. 26 Thus, shifting your biological clock, particularly toward less sleep, is a stressful phenomenon that has adverse cardiovascular consequences.
In summary, the work of Anea and colleagues 15 has linked disruption of the rhythmic circadian gene expression to impaired vascular homeostasis manifest as endothelial dysfunction and impaired vascular remodeling, largely due to disruption of normal signaling through phosphoinositidedependent kinase 1, Akt, and eNOS. These findings highlight the role of rhythmic gene expression in the control of vascular homeostasis and will surely spark a search for the precise molecular link(s) that tie rhythmicity to phosphoinositidedependent kinase 1 /Akt signaling.
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